BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sanz RL, García Menéndez S, Inserra F, Ferder L, Manucha W. Sodium-glucose cotransporter-2 inhibitors protect tissues via cellular and mitochondrial pathways: Experimental and clinical evidence. World J Exp Med 2024; 14(2): 91519 [PMID: 38948421 DOI: 10.5493/wjem.v14.i2.91519]
URL: https://www.wjgnet.com/2220-315x/full/v14/i2/91519.htm
Number Citing Articles
1
Mayra Trentin-Sonoda, Yan Burelle, Alex Gutsol, Robert L. Myette, Richard L. Hébert. Canagliflozin Promotes Structural and Functional Changes in Proximal Tubular Cell Mitochondria of Hypertensive–Diabetic Mice. International Journal of Molecular Sciences 2025; 26(24) doi: 10.3390/ijms262411988
2
Weili Liu, Yingying Xu, Liling Xiao, Ke Li, Qiang Liu. Composite dietary antioxidant index is associated with the prevalence of metabolic syndrome in females: results from NHANES 2011–2016. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1529332
3
Linyi Zhong, Yiwen Guo, Jiaxuan Zong, Xiushan Yang, Jiaxing Sun, Yinwen Zhang, Jiyuan Fan, Yuanhe Feng, Siwen Wang, Yining Wang, Ke Du, Mengmeng Wang. Mitochondrial dysfunction and oxidative stress in OSAHS and associated comorbidities: Mechanism and potential targeted therapeutic strategies. Redox Biology 2026; 97 doi: 10.1016/j.redox.2026.104409
4
Shengzhe Yan, Minhui Luo, Rui Zhou, Fenfen Peng, Mingze Zhang, Yujie Feng, Liang Zhao, Li Yang, Yanzhen Cheng. Sodium-glucose cotransporter 2 inhibitors alleviate renal fibrosis in diabetic kidney disease by inhibiting Hmgcs2 and Btg2 in proximal tubular cells. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-06788-6